BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rabiei M, Kashanian S, Samavati SS, Derakhshankhah H, Jamasb S, McInnes SJP. Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target 2021;:1-11. [PMID: 34415800 DOI: 10.1080/1061186X.2021.1971236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Petersen A, Asnaz OH, Tadsen B, Greiner F. Decoupling of dust cloud and embedding plasma for high electron depletion in nanodusty plasmas. Commun Phys 2022;5:308. [DOI: 10.1038/s42005-022-01060-5] [Reference Citation Analysis]
2 Zhao J, Zhu J, Huang C, Zhu X, Zhu Z, Wu Q, Yuan R. Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1035151] [Reference Citation Analysis]
3 Balde A, Kim SK, Benjakul S, Nazeer RA. Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review. Int J Biol Macromol 2022;220:1464-79. [PMID: 36116588 DOI: 10.1016/j.ijbiomac.2022.09.116] [Reference Citation Analysis]
4 Abbas M, Alqahtani MS, Almohiy HM, Alqahtani FF, Alhifzi R, Jambi LK. The Potential Contribution of Biopolymeric Particles in Lung Tissue Regeneration of COVID-19 Patients. Polymers (Basel) 2021;13:4011. [PMID: 34833310 DOI: 10.3390/polym13224011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]